Themis Medicare Limited (BOM:530199)
India flag India · Delayed Price · Currency is INR
93.27
-1.15 (-1.22%)
At close: Apr 29, 2026

Themis Medicare Company Description

Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally.

It offers active pharmaceutical ingredients (APIs) and formulations used in various therapeutic areas, including anti-tuberculosis, analgesic and anti-inflammatory, analgesic and antispasmodic, analgesics, anesthesia, antacid-antiflatulent, anti-fungal, antibiotic, anti-diabetic, anti-emetic, anti-hypertensive, anti-allergic and anti-inflammatory, anti-allergic and appetite stimulant, anticoagulant, antifibrolytic, antimalarial, anti-muscarinic, antioxidant, calcium, cardiovascular, corticosteroid, electrolytes, expectorant, hematinic, hemostatic agent, hemostatic agent with anesthetic, hormones, immunomodulator with anti-viral, muscle relaxant, narcotic analgesic, neuropathy, nutraceuticals, PPI, probiotic, reversal for muscle relaxant, sedatives, skeletal muscle relaxant, skeletal muscle relaxant and analgesic and anti-inflammatory, vasodilator, vasopressors, and vitamins.

The company was formerly known as Themis Chemicals and changed its name to Themis Medicare Limited in 2001.

Themis Medicare Limited was founded in 1952 and is based in Mumbai, India.

Themis Medicare Limited
Country India
Founded 1952
Industry Drug Stores and Proprietary Stores
Employees 1,702
CEO Sachin Patel

Contact Details

Address:
11/12 Udyog Nagar Industrial Estate
Mumbai, Maharashtra 400104
India
Phone 91 22 6760 7080
Website themismedicare.com

Stock Details

Ticker Symbol 530199
Exchange Bombay Stock Exchange
Fiscal Year April - March
Reporting Currency INR
SIC Code 5912

Key Executives

Name Position
Sachin Patel Chief Executive Officer
Tushar Dalal Chief Financial Officer
Raj Kumar Chief Operating Officer